Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Metabolism and nutrition disorders – page 29

  • 741 clinical trials
  • 263 recruiting
  • 237 conditions
  • 26 countries

Conditions in this area

237 conditions with trials, the busiest first

Obesity116Type 2 diabetes mellitus83Overweight51Type 1 diabetes mellitus38Endocrine ophthalmopathy26Metabolic dysfunction-associated steatohepatitis22Diabetes mellitus21Non-alcoholic steatohepatitis17Type IIa hyperlipidaemia15Glycogen storage disease type II14Hypercholesterolaemia14Diabetic foot13Diabetic retinal oedema13Diabetic neuropathy12Alpha-1 antitrypsin deficiency11Chronic kidney disease10Fabry's disease10Osteoporosis10Hypertriglyceridaemia9Hypoparathyroidism9Acromegaly8Dyslipidaemia8Iron deficiency8Phenylketonuria8+213

Clinical trials in Metabolism and nutrition disorders

741 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

741 clinical trials

Diabetic nephropathy+2

Not yet recruiting

Study on Aspirin's Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Acetylsalicylic Acid
  • Sponsor:Steno Diabetes Center Copenhagen

Obesity

Not yet recruiting

Study on the Effects of Semaglutide on Liver Fat in Obese Patients

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Semaglutide
  • Sponsor:Institut Klinicke A Experimentalni Mediciny

Vitamin B12 deficiency

Not yet recruiting

Study of High-Dose Hydroxocobalamin for Patients with Cobalamin Deficiency

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:COBALAMIN
  • Sponsor:Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Compostela

Diabetic foot

Not yet recruiting

Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Aup1602-C
  • Sponsor:Aurealis Oy

Hyperadrenocorticism

Not yet recruiting

Study on Using [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Patients with Cushing's Disease

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Fluoroethyltyrosine F-18
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Obesity

Not yet recruiting

A study of orismilast alone or combined with semaglutide for weight management in people with obesity

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Orismilast
  • Sponsor:Gentofte Hospital

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
  • Sponsor:Tourmaline Bio Inc.

Biotinidase deficiency

Not yet recruiting

Study on the Effectiveness of Biotin and Biotin Sodium for Children with Metabolic Disorders

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Biotin
  • Sponsor:Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Compostela

Thyroid mass+4

Not yet recruiting

Study Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide (131I)
  • Sponsor:Rijnstate Ziekenhuis Stichting

Type 1 diabetes mellitus

Not yet recruiting

A study evaluating a combination of glucagon and insulin lispro to improve insulin absorption in adults with Type 1 diabetes

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Glucagon
  • Sponsor:St. Olavs Hospital HF

Diabetic foot

Not yet recruiting

Study on the Safety and Effects of Udonitrectag for Treating Diabetic Foot Ulcers in Patients

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:UDONITRECTAG
  • Sponsor:Mimetech S.r.l.

Anorexia nervosa

Not yet recruiting

Study of oral lidocaine (ORE-001) to reduce abdominal discomfort and early satiety in patients with anorexia nervosa

Investigational
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Lidocaine Hydrochloride Monohydrate
  • Sponsor:Orexa B.V.

Substances studied in this area

The therapies tested most often in Metabolism and nutrition disorders trials.

Semaglutide76 clinical trialsSodium Chloride25 clinical trialsDapagliflozin23 clinical trialsEmpagliflozin16 clinical trialsCagrilintide15 clinical trialsPlacebo15 clinical trialsColecalciferol14 clinical trialsTirzepatide13 clinical trialsParacetamol12 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.